Co-Diagnostics, Inc.
CODX · XNASCIK 1692415fmd_1KXGF7VBF29XRS2XJCE6BVWZNDManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2016 to Sep 30, 2026, 42 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | 0 | 0 | 0 | 75 | 98 | 34 | 7 | 4 | 1 |
| Cost of revenue | – | 0 | 0 | 0 | 17 | 12 | 5 | 4 | 1 | 0 |
| Gross profit | – | 0 | 0 | 0 | 58 | 86 | 29 | 3 | 3 | 0 |
| Realized investment gains (losses) | – | – | – | – | – | – | – | 2 | 1 | 1 |
| Research and development | 1 | 1 | 1 | 1 | 3 | 15 | 17 | 23 | 21 | 19 |
| Selling, general and administrative | 1 | 4 | 5 | 5 | 13 | 25 | 22 | 21 | 21 | 11 |
| Total operating expenses | 2 | 5 | 6 | 6 | 16 | 40 | 56 | 45 | 43 | 51 |
| Operating income | (2) | (5) | (6) | (6) | 42 | 46 | (27) | (43) | (40) | (50) |
| Interest expense | 0 | 0 | 0 | 0 | – | – | – | – | – | – |
| Other non-operating income (expense) | – | (2) | (0) | (0) | 1 | (0) | 8 | 5 | 2 | 2 |
| Income before taxes | (2) | (7) | (6) | (6) | 43 | 46 | (19) | (38) | (38) | (49) |
| Income tax expense | – | – | – | – | 0 | 9 | (5) | (3) | 0 | (2) |
| Net income from continuing operations | – | – | – | – | 42 | 37 | (14) | (35) | (38) | (47) |
| Net income | (2) | (7) | (6) | (6) | 42 | 37 | (14) | (35) | (38) | (47) |